Background and Definitions. Ymabs and Institution have entered into an Exclusive License Agreement dated as of August 20, 2015 (the “License Agreement”) pursuant to which, among other things, (i) Ymabs has obtained exclusive license rights to the Licensed Products (as defined in the License Agreement) and (ii) Institution has agreed to transfer clinical data and databases, regulatory files and other Licensed Know-How to Ymabs and Ymabs’s designees. Capitalized terms used, but not defined in this Agreement, are used as defined in the License Agreement.
Appears in 3 contracts
Sources: Master Data Services Agreement (Y-mAbs Therapeutics, Inc.), Master Data Services Agreement (Y-mAbs Therapeutics, Inc.), Master Data Services Agreement (Y-mAbs Therapeutics, Inc.)